FDA — authorised 21 November 2020
- Marketing authorisation holder: Regeneron Pharmaceuticals, Inc.
- Status: approved
🇺🇸 IMDEVIMAB in United States
FDA authorised IMDEVIMAB on 21 November 2020
Marketing authorisation
IMDEVIMAB in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is IMDEVIMAB approved in United States?
Yes. FDA authorised it on 21 November 2020.
Who is the marketing authorisation holder for IMDEVIMAB in United States?
Regeneron Pharmaceuticals, Inc. holds the US marketing authorisation.